Back

Sexual functioning after the age of 40 in adults with moderate or severe congenital heart disease

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease: medical treatment Adult Congenital Heart Disease (ACHD) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Bengt Johansson

Umea University, Umea (Sweden)

8 More presentations in this session

Presentation thumbnail
Dapagliflozin prevents fibrogenic activation in endocardial endothelial cells under altered flow
Ms J. Gaal (Boston, US) Doctor I. Friehs (Boston, US)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitors for the treatment of single ventricle circulatory failure in adults with congenital heart disease
Doctor R. Neijenhuis (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Results of CHASM IN ACHD (peer CoacHing Adaptive Self-Management INterventions for young Adults with Congenital Heart Disease) study
Doctor R. Krasuski (Durham, US)
Abstract Slides Video
Presentation thumbnail
Sacubitril/ valsartan in patients with congenital heart disease: a systematic review and meta-analysis
Doctor D. Ntiloudi (Pireas, GR)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter-2 inhibitor use in children with left ventricular systolic dysfunction: a matched case-control analysis
Doctor D. Newland (Seattle, US)
Abstract Slides Video

Access the full session

Session thumbnail
Adult congenital heart disease: medical treatment

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Frailty and cognitive function after the age of 40 in adults with moderate or severe congenital heart disease
thumbnail
Congress Presentation
Late mortality in adults with congenital heart disease: the growing impact of acquired cardiovascular risk factors
thumbnail
Congress Presentation
Examining the impact of social determinants of health on the clinical outcomes of young adults with congenital heart disease: a register study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources